🗞️ The COVID-19 Drug Interactions April Newsletter is out, with details about our new French translation 👇👇

Another new medication for primary biliary cholangitis (PBC) has been added to the checker - Bezafibrate. All of our summary tables have been updated to include bezafibrate, and a download of the new interactions is available for our mobile apps.

We've added a new medication for primary biliary cholangitis (PBC) to our drug interaction checker: Elafibranor (Iqirvo®). All of our summary tables have been updated to include elafibranor and a download is available of the new interactions for our mobile apps.

💊 New comedication added to the COVID-19 drug interactions checker, Serdexmethylphenidate to the ADHD agents class

Still time to register for The Liverpool Course: COVID-19. We have a great programme lined up with fantastic speakers! Not to be missed! To register: www.covid19-druginteractions.org/site_news/237 #druginteractions #covid19 #DDIs #webinar

Join us online from 3PM GMT on Wednesday 18th February for The Liverpool Course: COVID-19! We have a great line-up of speakers and presentations focusing on the clinical management of DDIs in COVID-19. For more info and free registration 👉 www.covid19-druginteractions.org/site_news/237

Join us online from 3PM GMT on Wednesday 18th February for The Liverpool Course: COVID-19! We have a great line-up of speakers and presentations focusing on the clinical management of DDIs in COVID-19. For more info and free registration 👉 www.covid19-druginteractions.org/site_news/237

🗞️ Covid-19 Drug Interactions December newsletter is now out 👇👇 mailchi.mp/82547611b8fa...

Join us on Wed 18th February 2026 from 3PM GMT for the Liverpool Course: COVID-19! Talks and case-based presentations from expert speakers, focused on the clinical management of DDIs in COVID-19. Program and registration here 👉 tinyurl.com/LiverpoolCou... #covid19 #DDIs #druginteraction #webinar

The University of Liverpool Drug Interactions Group presents The Liverpool Course: COVID-19. Join us on Zoom webinar on Wednesday 3rd December 2025 at 3PM GMT.

💉 New COVID-19 therapy added to the drug interactions checker: Pemivibart, for use as pre-exposure prophylaxis. www.covid19-druginteractions.org/site_news/203

🗞️ Our September newsletter is out - big list of new comedications added to the drug interaction checker 👇 mailchi.mp/e60c8c9f4cba...

🚦Interaction colour changes! 🟢 Green ➡️ 🟡Yellow Imatinib x bilastine Remdesivir x bilastine 🟠 Amber ➡️ 🟡 Yellow Imatinib x cyclobenzaprine

💊 New comedications on the COVID-19 website: Antibacterials: Gatifloxacin, Nafcillin, Neomycin, Roxithromycin Anticoagulants, Antiplatelets and Fibrinolytics: Nadroparin Anticonvulsants: Felbamate Antihistamines: Clemastine (1/2)

🗞️ June newsletter for COVID-19 Drug Interactions is out. Read: mailchi.mp/bda7cc33b18c... Subscribe: eepurl.com/iiC6r9

💊 New drug for PBC added to the Hepatology Drug Interactions checker: seldelapar (Livdelzi®, Lyvdelzi®). Click to read the site news update 👇 www.hep-druginteractions.org/site_updates...

We have removed two obsolete therapies (Bamlanivimab/Etesevimab and Bebtelovimab) from the COVID-19 drug interaction checker. This allows us to focus on clinical need when preparing our drug interaction summaries.

The following new comedications have been added to the COVID-19 drug interaction checker: Anaesthetics and Muscle Relaxants: Esketamine (anaesthetic) Analgesics: Lornoxicam (Chlortenoxicam) Antibacterials: Gemifloxacin (1/2)

Our colleagues at Clinical Cases DDIs are looking for cases of interactions between unboosted INSTIs and inducers. Submit yours for a chance at winning a grant to attend a medical congress of your choice! 👉 clinicalcasesddis.com

Learn more and see if you qualify: www.agiletrial.net #COVID19 #clinicaltrial @nhsuhlg-ri.bsky.social @nhsuhlg.bsky.social @livuninews.bsky.social @livuniresearch.bsky.social @livuni-ismib.bsky.social @livunihls.bsky.social

💊 New comedications added to the drug interaction checker: betamethasone (topical) added to Steroids and fosphenytoin added to Anticonvulsants. www.covid19-druginteractions.org

🚦Updates to Paxlovid interactions: 97 yellow interactions with 5-day administration reviewed, 9 changed to 🟢GREEN, 3 changed to 🟠AMBER, and 85 kept as 🟡YELLOW with the additional comment that “coadministration has not been studied, but can be considered”.

🫘Our Renal Dosing Guidance has been updated to include new dosing information for renal impairment in the Paxlovid label: www.covid19-druginteractions.org/prescribing_... www.covid19-druginteractions.org/prescribing_...

🗞️Our March newsletter is out! Read online: mailchi.mp/81c8ef3e9700... or subscribe: eepurl.com/iiC6r9

Site updates for January and February are available on our site news page: several changes to interactions with Paxlovid! www.covid19-druginteractions.org/site_news/167

💊 New comedication added to the drug interaction checker to the Anti-convulsants class: Fosphenytoin

New paper celebration! @VirTUAL_UoL @EDCTP analysis of intracellular atazanavir/ritonavir with rifampicin. This mirrors what we saw in plasma, supporting that increasing 300/100 from once to twice daily safely overcomes the DDI #AtTheEquatorUG ascpt.onlinelibrary.wiley.com/doi/10.1002/...

Updates to the COVID-19 Drug Interaction checker this month: 💊 One new comedication - Betamethasone (topical) 🚦 424 interactions revised, resulting in 13 colour changes 💓 Latest long QT advice from CredibleMeds incorporated